To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint (TMJ) arthritis, and systemic JIA with and without macrophage activation syndrome. Recommendations regarding tapering and discontinuing treat...
Chung, Sharon;
Langford, Carol;
Maz, Mehrdad;
Abril, Andy;
Gorelik, Mark;
Guyatt, Gordon;
Archer, Amy;
Conn, Doyt;
Full, Kathy;
Grayson, Peter;
Mustafa, Reem.
To provide evidence-based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Clinical questio...
Maz, Mehrdad;
Chung, Sharon;
Abril, Andy;
Langford, Carol;
Gorelik, Mark;
Guyatt, Gordon;
Archer, Amy;
Conn, Doyt;
Full, Kathy;
Grayson, Peter;
Ibarra, Maria;
Imundo, Lisa;
Mustafa, Reem.
To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, c...
Fraenkel, Liana;
Bathon, Joan;
England, Bryant;
St Clair, William;
Arayssi, Thurayya;
Carandang, Kristine;
Deane, Kevin;
Genovese, Mark;
Huston, Kent;
Kerr, Gail;
Akl, Elie;
Turner, Amy.
To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluat...
